Tumors generated by CSCs from MEL-1 emerged 53 days after the injection, although surprisingly, they were barely detected in mice injected with IFN-α treated CSCs showing a significant reduction in mean tumor weight (Figure 4A, bottom panel). The gene discussed is IFNA1; the disease is neoplasm.